Test ID CRDPS Creatine Disorders Panel, Serum
Ordering Guidance
For additional diagnostic testing, consider ordering CRDPU / Creatine Disorders Panel, Random, Urine.
Additional Testing Requirements
To diagnose all creatine deficiency syndromes, order CRDPU / Creatine Disorders Panel, Random, Urine in addition to this test.
Necessary Information
Patient's age and sex are required.
Specimen Required
Collection Container/Tube: Red top (serum gel/SST are not acceptable)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions: Centrifuge and aliquot serum into plastic vial. Send serum frozen.
Useful For
Evaluating patients with a clinical suspicion of arginine:glycine amidinotransferase deficiency,guanidinoacetate methyltransferase deficiency, and creatine transporter deficiency using serum specimens
Testing Algorithm
For more information see:
-Newborn Screen Follow-up for Guanidinoacetate Methyltransferase Deficiency
-Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm
If the patient has abnormal newborn screening results for guanidinoacetate methyltransferase deficiency, refer to the appropriate ACMG Newborn Screening ACT Sheet.(1)
Special Instructions
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Creatine Disorders Panel, SSpecimen Type
SerumSpecimen Minimum Volume
0.1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 14 days | |
Refrigerated | 7 days | ||
Ambient | 72 hours |
Reference Values
Creatine Disorders Panel Reference Values |
||||||
|
≤11 Months |
12-23 Months |
24-35 Months |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
38.6-96.8 |
39.0-97.0 |
38.2-96.5 |
38.6-96.5 |
37.7-96.0 |
38.2-96.0 |
Creatinine |
27.6-35.9 |
27.6-35.2 |
27.6-36.5 |
27.6-35.5 |
27.6-37.1 |
27.6-36.0 |
Guanidinoacetate |
0.7-2.0 |
0.7-2.1 |
0.7-2.0 |
0.7-2.1 |
0.7-2.0 |
0.7-2.1 |
Creatine/ |
≤3.07 |
≤3.60 |
≤3.02 |
≤3.54 |
≤2.96 |
≤3.48 |
Guanidinoacetate/ |
≤0.040 |
≤0.040 |
≤0.042 |
≤0.040 |
≤0.043 |
≤0.042 |
Guanidinoacetate/ |
≤0.051 |
≤0.081 |
≤0.051 |
≤0.080 |
≤0.051 |
≤0.079 |
|
3 Years |
4 Years |
5 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
37.1-95.5 |
37.7-95.3 |
36.0-94.4 |
36.8-94.1 |
34.6-93.2 |
35.6-92.7 |
Creatinine |
27.6-37.9 |
27.7-36.9 |
27.6-39.3 |
27.7-38.2 |
27.6-40.9 |
27.8-39.9 |
Guanidinoacetate |
0.7-2.1 |
0.7-2.2 |
0.7-2.1 |
0.7-2.2 |
0.7-2.1 |
0.7-2.2 |
Creatine/ |
≤2.89 |
≤3.40 |
≤2.77 |
≤3.26 |
≤2.64 |
≤3.09 |
Guanidinoacetate/ |
≤0.045 |
≤0.043 |
≤0.049 |
≤0.045 |
≤0.053 |
≤0.049 |
Guanidinoacetate/ |
≤0.050 |
≤0.077 |
≤0.050 |
≤0.075 |
≤0.049 |
≤0.072 |
|
6 Years |
7 Years |
8 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
33.0-91.7 |
34.3-91.0 |
31.2-90.0 |
32.7-89.2 |
29.2-88.1 |
31.0-87.3 |
Creatinine |
27.6-42.8 |
28.0-41.9 |
27.7-44.9 |
28.3-44.3 |
27.8-47.0 |
28.8-47.1 |
Guanidinoacetate |
0.7-2.1 |
0.7-2.3 |
0.7-2.1 |
0.8-2.3 |
0.8-2.1 |
0.8-2.4 |
Creatine/ |
≤2.49 |
≤2.91 |
≤2.33 |
≤2.70 |
≤2.17 |
≤2.49 |
Guanidinoacetate/ |
≤0.058 |
≤0.053 |
≤0.063 |
≤0.058 |
≤0.069 |
≤0.064 |
Guanidinoacetate/ |
≤0.049 |
≤0.069 |
≤0.048 |
≤0.066 |
≤0.047 |
≤0.063 |
|
9 Years |
10 Years |
11 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
27.2-85.9 |
29.3-85.2 |
25.2-83.7 |
27.4-83.1 |
23.4-81.3 |
25.7-80.9 |
Creatinine |
28.0-49.3 |
29.5-50.1 |
28.2-51.5 |
30.6-53.6 |
28.4-53.6 |
32.0-57.2 |
Guanidinoacetate |
0.8-2.2 |
0.8-2.5 |
0.9-2.2 |
0.9-2.6 |
0.9-2.2 |
1.0-2.6 |
Creatine/ |
≤2.02 |
≤2.28 |
≤1.86 |
≤2.07 |
≤1.72 |
≤1.87 |
Guanidinoacetate/ |
≤0.075 |
≤0.070 |
≤0.081 |
≤0.078 |
≤0.087 |
≤0.085 |
Guanidinoacetate/ |
≤0.047 |
≤0.060 |
≤0.046 |
≤0.057 |
≤0.045 |
≤0.055 |
|
12 Years |
13 Years |
14 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
21.7-78.7 |
23.9-78.6 |
20.3-76.2 |
22.3-76.2 |
19.0-73.6 |
20.8-73.8 |
Creatinine |
28.7-55.7 |
33.8-61.0 |
29.1-57.7 |
35.9-64.8 |
29.5-59.5 |
38.1-68.5 |
Guanidinoacetate |
0.9-2.2 |
1.0-2.7 |
1.0-2.3 |
1.1-2.8 |
1.0-2.3 |
1.1-2.9 |
Creatine/ |
≤1.58 |
≤1.68 |
≤1.45 |
≤1.50 |
≤1.33 |
≤1.34 |
Guanidinoacetate/ |
≤0.092 |
≤0.093 |
≤0.097 |
≤0.101 |
≤0.101 |
≤0.109 |
Guanidinoacetate/ |
≤0.044 |
≤0.053 |
≤0.043 |
≤0.051 |
≤0.042 |
≤0.050 |
|
15 Years |
16 Years |
17 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
18.1-71.1 |
19.5-71.2 |
17.4-68.7 |
18.4-68.6 |
16.9-66.5 |
17.4-65.9 |
Creatinine |
29.9-61.3 |
40.4-71.9 |
30.4-62.9 |
42.4-75.0 |
30.9-64.4 |
44.2-77.6 |
Guanidinoacetate |
1.0-2.3 |
1.2-2.9 |
1.1-2.3 |
1.3-3.0 |
1.1-2.3 |
1.3-3.1 |
Creatine/ |
≤1.22 |
≤1.20 |
≤1.12 |
≤1.07 |
≤1.04 |
≤0.97 |
Guanidinoacetate/ |
≤0.104 |
≤0.117 |
≤0.107 |
≤0.125 |
≤0.109 |
≤0.132 |
Guanidinoacetate/ |
≤0.041 |
≤0.049 |
≤0.040 |
≤0.048 |
≤0.040 |
≤0.048 |
|
18 Years |
19 Years |
20 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.7-64.4 |
16.6-63.3 |
16.6-62.7 |
15.8-60.7 |
16.5-61.1 |
15.2-58.3 |
Creatinine |
31.3-65.8 |
45.6-80.0 |
31.8-67.0 |
46.7-82.0 |
32.2-68.2 |
47.4-83.9 |
Guanidinoacetate |
1.1-2.4 |
1.4-3.1 |
1.1-2.4 |
1.4-3.2 |
1.1-2.4 |
1.5-3.2 |
Creatine/ |
≤0.98 |
≤0.87 |
≤0.93 |
≤0.80 |
≤0.89 |
≤0.73 |
Guanidinoacetate/ |
≤0.111 |
≤0.139 |
≤0.112 |
≤0.145 |
≤0.113 |
≤0.150 |
Guanidinoacetate/ |
≤0.039 |
≤0.047 |
≤0.038 |
≤0.047 |
≤0.038 |
≤0.046 |
|
21 Years |
22 Years |
23 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.6-59.8 |
14.7-56.0 |
16.6-58.8 |
14.2-54.0 |
16.7-57.9 |
13.7-52.2 |
Creatinine |
32.5-69.2 |
47.9-85.6 |
 32.8-70.2 |
48.2-87.2 |
 33.1-71.1 |
48.4-88.8 |
Guanidinoacetate |
1.1-2.4 |
1.5-3.2 |
1.1-2.5 |
1.5-3.3 |
1.1-2.5 |
1.6-3.3 |
Creatine/ |
≤0.87 |
≤0.68 |
≤0.85 |
≤0.64 |
≤0.84 |
≤0.61 |
Guanidinoacetate/ |
≤0.114 |
≤0.156 |
≤0.115 |
≤0.161 |
≤0.116 |
≤0.165 |
Guanidinoacetate/ |
≤0.037 |
≤0.045 |
≤0.037 |
≤0.045 |
≤0.037 |
≤0.044 |
|
24 Years |
25 Years |
26 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.7-57.2 |
13.3-50.6 |
16.7-56.5 |
12.9-49.3 |
16.7-56.0 |
12.5-48.1 |
Creatinine |
33.3-71.9 |
48.6-90.2 |
33.6-72.8 |
48.7-91.5 |
33.7-73.6 |
48.9-92.7 |
Guanidinoacetate |
1.1-2.5 |
1.6-3.3 |
1.1-2.5 |
1.6-3.3 |
1.1-2.6 |
1.6-3.4 |
Creatine/ |
≤0.84 |
≤0.58 |
≤0.84 |
≤0.56 |
≤0.84 |
≤0.54 |
Guanidinoacetate/ |
≤0.116 |
≤0.170 |
≤0.117 |
≤0.174 |
≤0.118 |
≤0.179 |
Guanidinoacetate/ |
≤0.036 |
≤0.043 |
≤0.036 |
≤0.043 |
≤0.036 |
≤0.042 |
|
27 Years |
28 Years |
29 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.7-55.5 |
12.1-47.1 |
16.6-55.1 |
11.8-46.3 |
16.5-54.7 |
11.5-45.4 |
Creatinine |
33.9-74.4 |
49.0-93.7 |
34.1-75.2 |
49.1-94.5 |
34.2-76.0 |
49.2-95.3 |
Guanidinoacetate |
1.1-2.6 |
1.6-3.4 |
1.1-2.6 |
1.6-3.4 |
1.1-2.6 |
1.6-3.4 |
Creatine/ |
≤0.84 |
≤0.52 |
≤0.84 |
≤0.51 |
≤0.84 |
≤0.49 |
Guanidinoacetate/ |
≤0.118 |
≤0.182 |
≤0.119 |
≤0.186 |
≤0.119 |
≤0.188 |
Guanidinoacetate/ |
≤0.036 |
≤0.042 |
≤0.036 |
≤0.041 |
≤0.036 |
≤0.041 |
|
30 Years |
31 Years |
32 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.4-54.2 |
11.3-44.7 |
16.4-53.8 |
11.1-43.9 |
16.3-53.4 |
11.0-43.2 |
Creatinine |
34.4-76.8 |
49.3-96.0 |
34.6-77.5 |
49.3-96.7 |
34.7-78.2 |
49.4-97.4 |
Guanidinoacetate |
1.2-2.7 |
1.6-3.5 |
1.2-2.7 |
1.6-3.5 |
1.2-2.7 |
1.6-3.5 |
Creatine/ |
≤0.84 |
≤0.48 |
≤0.83 |
≤0.47 |
≤0.83 |
≤0.46 |
Guanidinoacetate/ |
≤0.120 |
≤0.190 |
≤0.120 |
≤0.192 |
≤0.119 |
≤0.192 |
Guanidinoacetate/ |
≤0.036 |
≤0.041 |
≤0.036 |
≤0.042 |
≤0.037 |
≤0.042 |
|
33 Years |
34 Years |
35 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.3-53.0 |
10.9-42.5 |
16.4-52.7 |
10.8-41.7 |
16.4-52.3 |
10.7-41.0 |
Creatinine |
34.9-78.8 |
49.4-98.0 |
35.1-79.4 |
49.5-98.6 |
35.3-79.9 |
49.5-99.2 |
Guanidinoacetate |
1.2-2.8 |
1.6-3.5 |
1.2-2.8 |
1.6-3.5 |
1.2-2.8 |
1.6-3.4 |
Creatine/ |
≤0.82 |
≤0.45 |
≤0.82 |
≤0.45 |
≤0.82 |
≤0.44 |
Guanidinoacetate/ |
≤0.119 |
≤0.192 |
≤0.118 |
≤0.191 |
≤0.118 |
≤0.189 |
Guanidinoacetate/ |
≤0.037 |
≤0.042 |
≤0.037 |
≤0.042 |
≤0.037 |
≤0.042 |
|
36 Years |
37 Years |
38 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
16.5-52.0 |
10.7-40.2 |
16.7-51.6 |
10.6-39.5 |
16.9-51.3 |
10.6-38.9 |
Creatinine |
35.4-80.3 |
49.5-99.8 |
35.6-80.7 |
49.5-100.3 |
35.8-81.0 |
49.6-100.8 |
Guanidinoacetate |
1.2-2.8 |
1.6-3.4 |
1.2-2.8 |
1.6-3.4 |
1.2-2.9 |
1.6-3.4 |
Creatine/ |
≤0.82 |
≤0.44 |
≤0.82 |
≤0.44 |
≤0.83 |
≤0.44 |
Guanidinoacetate/ |
≤0.117 |
≤0.187 |
≤0.115 |
≤0.184 |
≤0.114 |
≤0.182 |
Guanidinoacetate/ |
≤0.037 |
≤0.042 |
≤0.037 |
≤0.042 |
≤0.036 |
≤0.042 |
|
39 Years |
40 Years |
41 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
17.1-51.1 |
10.6-38.2 |
17.3-50.9 |
10.7-37.7 |
17.5-50.8 |
10.7-37.2 |
Creatinine |
35.9-81.4 |
49.6-101.3 |
36.0-81.6 |
49.6-101.7 |
36.1-81.9 |
49.7-102.1 |
Guanidinoacetate |
1.2-2.9 |
1.6-3.4 |
1.2-2.9 |
1.6-3.4 |
1.2-2.9 |
1.6-3.4 |
Creatine/ |
≤0.83 |
≤0.44 |
≤0.83 |
≤0.44 |
≤0.84 |
≤0.44 |
Guanidinoacetate/ |
≤0.113 |
≤0.179 |
≤0.111 |
≤0.176 |
≤0.110 |
≤0.174 |
Guanidinoacetate/ |
≤0.036 |
≤0.041 |
≤0.036 |
≤0.041 |
≤0.036 |
≤0.040 |
|
42 Years |
43 Years |
44 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
17.7-50.8 |
10.8-36.7 |
17.8-50.8 |
10.9-36.3 |
17.8-50.9 |
11.0-36.0 |
Creatinine |
36.2-82.1 |
49.7-102.5 |
36.3-82.4 |
49.8-102.8 |
36.4-82.6 |
49.8-103.1 |
Guanidinoacetate |
1.2-3.0 |
1.6-3.3 |
1.2-3.0 |
1.6-3.3 |
1.2-3.0 |
1.6-3.3 |
Creatine/ |
≤0.84 |
≤0.44 |
≤0.84 |
≤0.43 |
≤0.84 |
≤0.43 |
Guanidinoacetate/ |
≤0.109 |
≤0.172 |
≤0.108 |
≤0.171 |
≤0.107 |
≤0.170 |
Guanidinoacetate/ |
≤0.036 |
≤0.039 |
≤0.036 |
≤0.039 |
≤0.036 |
≤0.038 |
|
45 Years |
46 Years |
47 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
17.7-51.0 |
11.1-35.6 |
17.6-51.2 |
11.2-35.3 |
17.4-51.4 |
11.3-35.1 |
Creatinine |
36.4-82.8 |
49.9-103.4 |
36.5-83.0 |
49.9-103.6 |
36.5-83.2 |
49.9-103.9 |
Guanidinoacetate |
1.2-3.0 |
1.7-3.3 |
1.2-3.1 |
1.7-3.3 |
1.2-3.1 |
1.7-3.3 |
Creatine/ |
≤0.84 |
≤0.42 |
≤0.83 |
≤0.41 |
≤0.83 |
≤0.40 |
Guanidinoacetate/ |
≤0.106 |
≤0.169 |
≤0.106 |
≤0.168 |
≤0.106 |
≤0.167 |
Guanidinoacetate/ |
≤0.037 |
≤0.038 |
≤0.037 |
≤0.037 |
≤0.037 |
≤0.037 |
|
48 Years |
49 Years |
50 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
17.2-51.7 |
11.5-34.8 |
17.1-51.9 |
11.6-34.6 |
17.0-52.1 |
11.7-34.4 |
Creatinine |
36.6-83.4 |
49.9-104.1 |
36.6-83.5 |
49.9-104.2 |
36.7-83.7 |
49.9-104.4 |
Guanidinoacetate |
1.2-3.1 |
1.7-3.3 |
1.2-3.1 |
1.7-3.3 |
1.2-3.1 |
1.7-3.3 |
Creatine/ |
≤0.82 |
≤0.39 |
≤0.82 |
≤0.38 |
≤0.82 |
≤0.38 |
Guanidinoacetate/ |
≤0.106 |
≤0.166 |
≤0.106 |
≤0.164 |
≤0.105 |
≤0.163 |
Guanidinoacetate/ |
≤0.038 |
≤0.036 |
≤0.038 |
≤0.036 |
≤0.039 |
≤0.036 |
|
51 Years |
52 Years |
53 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
17.0-52.2 |
11.9-34.3 |
17.1-52.3 |
12.0-34.3 |
17.3-52.4 |
12.2-34.3 |
Creatinine |
36.8-83.9 |
49.8-104.6 |
36.8-84.0 |
49.8-104.8 |
36.9-84.2 |
49.8-104.9 |
Guanidinoacetate |
1.2-3.1 |
1.7-3.3 |
1.2-3.1 |
1.7-3.2 |
1.2-3.1 |
1.6-3.2 |
Creatine/ |
≤0.82 |
≤0.37 |
≤0.82 |
≤0.37 |
≤0.82 |
≤0.38 |
Guanidinoacetate/ |
≤0.105 |
≤0.161 |
≤0.104 |
≤0.159 |
≤0.103 |
≤0.157 |
Guanidinoacetate/ |
≤0.039 |
≤0.036 |
≤0.039 |
≤0.036 |
≤0.039 |
≤0.036 |
|
54 Years |
55 Years |
56 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
17.6-52.5 |
12.4-34.3 |
18.1-52.6 |
12.5-34.4 |
18.6-52.7 |
12.6-34.4 |
Creatinine |
37.0-84.4 |
49.8-105.0 |
37.1-84.5 |
49.8-105.2 |
37.2-84.7 |
49.8-105.3 |
Guanidinoacetate |
1.2-3.1 |
1.6-3.2 |
1.2-3.1 |
1.6-3.2 |
1.2-3.1 |
1.6-3.2 |
Creatine/ |
≤0.82 |
≤0.38 |
≤0.83 |
≤0.39 |
≤0.84 |
≤0.40 |
Guanidinoacetate/ |
≤0.102 |
≤0.155 |
≤0.100 |
≤0.154 |
≤0.099 |
≤0.152 |
Guanidinoacetate/ |
≤0.039 |
≤0.036 |
≤0.039 |
≤0.036 |
≤0.039 |
≤0.036 |
|
57 Years |
58 Years |
59 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
19.2-52.9 |
12.7-34.4 |
19.9-53.1 |
12.8-34.3 |
20.5-53.3 |
12.8-34.2 |
Creatinine |
37.3-84.9 |
49.8-105.4 |
37.4-85.1 |
49.8-105.5 |
37.6-85.2 |
49.8-105.6 |
Guanidinoacetate |
1.2-3.0 |
1.6-3.2 |
1.3-3.0 |
1.6-3.2 |
1.3-3.0 |
1.6-3.2 |
Creatine/ |
≤0.84 |
≤0.40 |
≤0.85 |
≤0.41 |
≤0.86 |
≤0.42 |
Guanidinoacetate/ |
≤0.098 |
≤0.151 |
≤0.096 |
≤0.151 |
≤0.095 |
≤0.150 |
Guanidinoacetate/ |
≤0.039 |
≤0.036 |
≤0.038 |
≤0.036 |
≤0.038 |
≤0.036 |
|
60 Years |
61 Years |
62 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
21.0-53.6 |
12.8-34.1 |
21.5-53.9 |
12.7-34.0 |
21.9-54.2 |
12.6-33.9 |
Creatinine |
37.8-85.4 |
49.9-105.7 |
38.0-85.5 |
49.9-105.9 |
38.3-85.7 |
49.9-106.0 |
Guanidinoacetate |
1.3-2.9 |
1.6-3.2 |
1.3-2.9 |
1.6-3.1 |
1.3-2.9 |
1.6-3.1 |
Creatine/ |
≤0.87 |
≤0.43 |
≤0.87 |
≤0.44 |
≤0.88 |
≤0.44 |
Guanidinoacetate/ |
≤0.094 |
≤0.150 |
≤0.093 |
≤0.150 |
≤0.093 |
≤0.150 |
Guanidinoacetate/ |
≤0.037 |
≤0.036 |
≤0.036 |
≤0.035 |
≤0.036 |
≤0.035 |
|
63 Years |
64 Years |
65 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
22.2-54.6 |
12.4-33.7 |
22.3-55.0 |
12.3-33.6 |
22.5-55.5 |
12.2-33.4 |
Creatinine |
38.7-85.8 |
50.0-106.1 |
39.1-85.9 |
50.0-106.3 |
39.6-86.1 |
50.1-106.4 |
Guanidinoacetate |
1.3-2.8 |
1.6-3.1 |
1.3-2.8 |
1.6-3.1 |
1.3-2.8 |
1.6-3.1 |
Creatine/ |
≤0.88 |
≤0.45 |
≤0.89 |
≤0.46 |
≤0.89 |
≤0.46 |
Guanidinoacetate/ |
≤0.092 |
≤0.150 |
≤0.092 |
≤0.149 |
≤0.091 |
≤0.149 |
Guanidinoacetate/ |
≤0.035 |
≤0.035 |
≤0.034 |
≤0.034 |
≤0.034 |
≤0.034 |
|
66 Years |
67 Years |
68 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
22.6-55.9 |
12.3-33.1 |
22.7-56.3 |
12.3-32.8 |
22.9-56.7 |
12.5-32.4 |
Creatinine |
40.2-86.2 |
50.2-106.6 |
40.7-86.3 |
50.3-106.7 |
41.3-86.5 |
50.4-106.9 |
Guanidinoacetate |
1.3-2.7 |
1.6-3.1 |
1.3-2.7 |
1.6-3.0 |
1.4-2.7 |
1.6-3.0 |
Creatine/ |
≤0.90 |
≤0.47 |
≤0.90 |
≤0.48 |
≤0.90 |
≤0.48 |
Guanidinoacetate/ |
≤0.091 |
≤0.149 |
≤0.090 |
≤0.148 |
≤0.090 |
≤0.148 |
Guanidinoacetate/ |
≤0.034 |
≤0.034 |
≤0.033 |
≤0.034 |
≤0.033 |
≤0.034 |
|
69 Years |
70 Years |
≥ 71 Years |
|||
Female |
Male |
Female |
Male |
Female |
Male |
|
Creatine |
23.2-57.0 |
12.8-32.0 |
23.6-57.2 |
13.1-31.4 |
24.1-57.3 |
13.6-30.8 |
Creatinine |
41.9-86.6 |
50.5-107.1 |
42.4-86.8 |
50.7-107.4 |
42.8-86.9 |
50.8-107.6 |
Guanidinoacetate |
1.4-2.6 |
1.6-3.0 |
1.4-2.6 |
1.6-3.0 |
1.4-2.5 |
1.5-3.0 |
Creatine/ |
≤0.90 |
≤0.48 |
≤0.90 |
≤0.48 |
≤0.90 |
≤0.48 |
Guanidinoacetate/ |
≤0.090 |
≤0.148 |
≤0.090 |
≤0.148 |
≤0.090 |
≤0.148 |
Guanidinoacetate/ |
≤0.033 |
≤0.034 |
≤0.033 |
≤0.034 |
≤0.033 |
≤0.034 |
Day(s) Performed
Tuesday
Report Available
3 to 9 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82540
82565
82542
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CRDPS | Creatine Disorders Panel, S | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
608077 | Interpretation | 59462-2 |
608078 | Creatine | 15045-8 |
608079 | Creatinine | 14682-9 |
608080 | Guanidinoacetate | 33244-5 |
608081 | Creatine/Creatinine | In Process |
610857 | Guanidinoacetate/Creatine | In Process |
610858 | Guanidinoacetate/Creatinine | In Process |
608082 | Reviewed By | 18771-6 |